[Non-apoptotic programmed cell death induced by extract of Spatholobus suberctus in human lung cancer A549 cells]

Yong Tang1, Qi Fu, Wei He

  • 1Beijing Hospital of Chinese Medicine alias Capital University of Medical Sciences, Beijing 100010, China.

Abstract

Insights

The Spatholobus suberctus extract exhibits potent cytotoxic effects against human lung cancer A549 cells, inducing S-phase delay and non-apoptotic programmed cell death. This natural compound demonstrates direct anti-tumor activity.

Area of Science:

  • Phytochemistry
  • Cancer Biology
  • Cellular Mechanisms

Context:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Natural products are increasingly investigated for their therapeutic potential against various cancers.
  • Spatholobus suberctus is a traditional medicinal plant with potential anti-cancer properties.

Purpose:

  • To investigate the cytotoxic activity of Spatholobus suberctus extract on human lung cancer A549 cells.
  • To elucidate the underlying mechanisms of cell death induced by the extract.
  • To evaluate the impact of the extract on cell cycle progression and apoptosis.

Summary:

  • Spatholobus suberctus extract demonstrated significant cytotoxic effects on A549 cells with an IC50 of 25.54 mg/L within 24 hours.
  • The extract induced an increase in S-phase cells and a decrease in G0-G1 and G2-M phases, indicating an S-phase delay.
  • Cell death was characterized by nuclear pyknosis, cytoplasmic vacuolization, and phosphatidylserine externalization, but lacked detectable DNA fragmentation or significant caspase-3 activation, suggesting non-apoptotic programmed cell death.

Impact:

  • The findings support the direct anti-tumor activity of Spatholobus suberctus extract.
  • This research provides mechanistic insights into the anti-cancer effects of the plant extract.
  • The study highlights the potential of Spatholobus suberctus as a source for novel lung cancer therapeutics.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.3K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K